Protect You Both

National Medicine Association PSA: Covid and Pregnancy: Watch Video 

Centers for Disease Control and Prevention

Low vaccine booster rates are now a key factor in COVID-19 deaths – and racial disparities in booster rates persist, August 30, 2022

The Conversation piece discusses the emerging that evidence that only 29% of Black adults had received boosters by January 2022, as compared with 45% of white adults and 52% of Asian American adults. Studies suggest that adults age 50 and older who receiver a booster shot have 90% lower death rates from COVID-19 than those who only receive the initial vaccine regimen. Booster campaigns and strategies to make boosters more accessible can help address the disparities.

COVID-19 Vaccination During Pregnancy Is Key to Saving Lives, Medical Experts Urge, December 6, 2021

Joint statement between the American College of Nurse-Midwives ¦American College of Obstetricians and Gynecologists ¦ American Academy of Family Physicians ¦ American Society for Reproductive Medicine ¦ Association of Women’s Health, Obstetric and Neonatal Nurses ¦ National Hispanic Medical Association ¦ National Medical Association ¦ National Rural Health Association ¦ Nurse Practitioners in Women’s Health ¦ Society for Maternal-Fetal Medicine

Statement of Strong Medical Consensus for Vaccination of Pregnant Individuals Against COVID-19, August 2021

Joint statement between the American College of Obstetricians and Gynecologists | American Academy of Family Physicians | American Academy of PAs | American Academy of Pediatrics | American Association of Nurse Practitioners |American College of Nurse-Midwives | American College of Osteopathic Obstetricians & Gynecologists | American College of Physicians | American Pharmacists Association| Association of Immunization Managers |Association of State and Territorial Health Officials | Association of Women’s Health, Obstetric and Neonatal Nurses | Infectious Diseases Society of America | Infectious Diseases Society for Obstetrics and Gynecology | National Association of Chain Drug Stores |National Association of County & City Health Officials | National Association of Nurse Practitioners in Women’s Health |National Foundation for Infectious Diseases | National Hispanic Medical Association | North American Society for Pediatric and Adolescent Gynecology | Society for Maternal-Fetal Medicine | Vaccinate Your Family

American College of Obstetricians and Gynecologists: Answers from Ob-Gyns about COVID-19 vaccines

ACOG Fast Facts about COVID-19 and Pregnancy

For pregnant individuals
Coronavirus (COVID-19), Pregnancy, and Breastfeeding: A Message for Patients
Practice advisory

• Lipschuetz, M., Guedalia, J., Cohen, S.M. et al. Maternal third dose of BNT162b2 mRNA vaccine and risk of infant COVID-19 hospitalization. Nat Med (2023).

• Shook, Lydia L. MD; Edlow, Andrea G. MD, MSc. Safety and Efficacy of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines During Lactation. Obstetrics & Gynecology 141(3):p 483-491, March 2023.

• Hui, L., Marzan, M. B., Rolnik, D. L., Potenza, S., Pritchard, N., Said, J. M., Palmer, K. R., Whitehead, C. L., Sheehan, P. M., Ford, J., Mol, B. W., & Walker, S. P. (2022). Reductions in stillbirths and preterm birth in COVID-19 vaccinated women: A multi-center cohort study of vaccination uptake and perinatal outcomes. American Journal of Obstetrics and Gynecology. 

• Schwartz, D. A., Mulkey, S. B., & Roberts, D. J. (2022). SARS-COV-2 placentitis, stillbirth, and maternal COVID-19 vaccination: Clinical–pathologic correlations. American Journal of Obstetrics and Gynecology. 

• Schwartz, D. A., Mulkey, S. B., & Roberts, D. J. (2022). SARS-COV-2 placentitis, stillbirth, and maternal COVID-19 vaccination: Clinical–pathologic correlations. American Journal of Obstetrics and Gynecology.

• Guedalia, J., Lipschuetz, M., Calderon-Margalit, R. et al. Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in Israel. Nat Commun 2022; 13, 6961.

• Atsuyuki W, Yasuhara J, Iwagami M et al. Peripartum Outcomes Associated With COVID-19 Vaccination During Pregnancy. October 2022. JAMA Pediatrics>; published online.

• Schrag, SJ, Phil D, Verani JR, Dixon BE et al. Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States, September 2022. JAMA; 5(9): e2233273

• Halasa  NB, Olson SM, Staat MA, et al., Maternal Vaccination and Risk of Hospitalization for Covid-19 amount Infants, The New England Journal of Medicine 2022; 387(2): 109-119.

• Kugelman, Nahshon, Shaked-Mishan, et al. Third trimester messenger RNA COVID-19 booster vaccination upsurge maternal and neonatal SARS-CoV-2 immunoglobulin G antibody levels at birth, July 2022. European Journal of Obstetrics & Gynecology and Reproductive Biology>; 274: 148.

• Halasa NB, Olson SM, Staat MA, et al. Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged-17 States, July 2021-January 2022. MMWR Morbidity and mortality weekly report 2022; 71(7): 264.

• Gray KJ, Bordt EA, Atyeo C, et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. American Journal of Obstetrics and Gynecology 2021; 225(3): 303.e1-.e17.

• Kashani-Ligumsky L, Lopian M, Cohen R, et al. Titers of SARS CoV-2 antibodies in cord blood of neonates whose mothers contracted SARS CoV-2 (COVID-19) during pregnancy and in those whose mothers were vaccinated with mRNA to SARS CoV-2 during pregnancy. Journal of Perinatology 2021.

• Perl SH, Uzan-Yulzari A, Klainer H, et al. SARS-CoV-2–specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women. Jama 2021; 325(19): 2013-4.

• Shook LL, Atyeo CG, Yonker LM, et al. Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection. JAMA 2022.

• Dagan N, Barda N, Biron-Shental T, et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nature medicine 2021; 27(10): 1693-5.

• Kelly JC, Carter EB, Raghuraman N, et al. Anti–severe acute respiratory syndrome coronavirus 2 antibodies induced in breast milk after Pfizer-BioNTech/BNT162b2 vaccination. American Journal of Obstetrics and Gynecology 2021; 225(1): 101-3.

• Jakuszko K, Koscielska-Kasprzak K, Zabinska M, et al. Immune response to vaccination against COVID-19 in breastfeeding health workers. Vaccines 2021; 9(6): 663.

• Goldshtein I, Nevo D, Steinberg DM, et al. Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women. JAMA 2021; 326(8): 728.

• Kharbanda EO, Haapala J, Desilva M, et al. Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy. JAMA 2021; 326(16): 1629.

• Zauche LH, Wallace B, Smoots AN, et al. Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion. New England Journal of Medicine 2021; 385(16): 1533-5.

• Shimabukuro TT, Kim SY, Myers TR, et al. Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. New England Journal of Medicine 2021; 384(24): 2273-82.

• Young BE, Seppo AE, Diaz N, et al. Association of Human Milk Antibody Induction, Persistence, and Neutralizing Capacity With SARS-CoV-2 Infection vs mRNA Vaccination. JAMA pediatrics 2021.

CDC COVID Pregnancy Data Tracker – Updated COVID-19 risks during pregnancy. Also includes resources and tools to help pregnant or breastfeeding women, vaccination rates among pregnant women, birth and infant outcomes, and steps for pregnant or lactating mothers to help protect themselves and their children from COVID-19.

WHO COVID-19 Dashboard – Visualize COVID-19 data via cases, death, or vaccinations.